Bayer's move leaves Merck still out in front – with an approval for gefapixant for cough in Japan where the drug is known as Lyfnua – but clearly casts a shadow on the class as a whole.

March 17, 2025 Bayer welcomes new law in U.S. state to better shield it against glyphosate litigation Bayer said on Monday that it welcomed a new law about to be passed in the U.S. state of ...

Cash call worth about $9 billion based on current value Company says would only use the extra capital if essential Bayer has paid $10 billion on Roundup settlements Share price falls more than 6% ...

Bayer has filed its mineralocorticoid receptor antagonist (MRA) finerenone as a treatment for a common form of heart failure in the EU, fulfilling a key 2025 pipeline objective. The pharma group ...